Articles from Adverse Event Reporting News (December 3, 2007)

Title	Author	Type	Words
'Inadequacies' at FDA risk lives, Science Board subcommittee says.			1234
Abbott stent gets backing of FDA panel.			356
Avandia may increase risk of osteoporsis.			356
Bodee recalls dietary supplement; may have harmful ingredients.		Brief article	132
China to extend 'arduous' drug industry clean-up.		Brief article	322
Conferences.		Calendar	155
FDA committee urges stronger warnings on asthma drugs for children.		Brief article	278
FDA issues early warning on Pfizer's anti-smoking drug.			367
FDA issues safety alert for pregnant patients using kidney transplant drug.		Brief article	107
FDA panel backs heart-pump device.			451
FDA staffer calls for new methods of testing diabetes drugs.			473
Former FDA Commissioner McClellan to chair Reagan-Udall Foundation.		Brief article	268
Guidance would allow drug makers to give doctors research on off-label use.			574
No new patients for Merck, Vertex trials.		Brief article	145
Panel seeks warning to prevent pediatric use of Provigil.		Brief article	169
Pfizer legal win might block some lawsuits over Celebrex.		Brief article	178
Roche accepts FDA's proposal for stronger warning on Tamiflu.		Brief article	281
Smith & Nephew recalls knee implants due to high iron content.		Brief article	203
U.K., Germany suspend marketing of Prexige.			474